Search results
Results from the WOW.Com Content Network
The Atlas is part of the genome project and participates in research on cancer epidemiology. The Atlas is accessed by: 1- researchers in cytogenetics , molecular biology , cell biology ; 2- clinicians, haematologists, cytogeneticists, pathologists, from the university hospitals, indeed, but also from general hospitals where the Atlas is one of ...
Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals [2] currently active in science, technology, and medicine.It was founded in 2007 by Kamila and Henry Markram. [1]
Experimental Biology and Medicine is a peer-reviewed scientific journal that covers experimental biological and medical research. The editor-in-chief is Nicola Conran ( University of Campinas ). It was established in 1903 as Proceedings of the Society for Experimental Biology and Medicine and is published, as of January 2024, by Frontiers Media ...
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist . [ 1 ] The name's etymological origin is the Greek word ὄγκος ( ónkos ), meaning "tumor", "volume" or "mass". [ 2 ]
The concept of the tumor microenvironment (TME) dates back to 1863 when Rudolf Virchow established a connection between inflammation and cancer. However, it was not until 1889 that Stephen Paget's seed and soil theory introduced the important role of TME in cancer metastasis, highlighting the intricate relationship between tumors and their surrounding microenvironment.
The related suffix -ome is used to address the objects of study of such fields, such as the genome, proteome or metabolome respectively. The suffix -ome as used in molecular biology refers to a totality of some sort; it is an example of a "neo-suffix" formed by abstraction from various Greek terms in -ωμα , a sequence that does not form an ...
Cancer biomarkers have also shown utility in monitoring how well a treatment is working over time. Much research is going into this particular area, since successful biomarkers have the potential of providing significant cost reduction in patient care, as the current image-based tests such as CT and MRI for monitoring tumor status are highly ...
The Annual Review of Cancer Biology was first published in 2017, making it the 47th journal title published by Annual Reviews. [5] The stated goals of the journal were to cover the biology of tumor cells, the interaction between the tumor cells and host cells, cancer genomes, drugs for treating cancer, and the resistance of cancer to certain drugs. [6]